22/02/2021
Semaglutide and tirzepatide, both once weekly injections, have shown significant reduction in body weight with tolerable side effects. These interventions are forecasting a shift in weight loss medication.
https://lifescite.com/new-weight-loss-paradigm-diabetic-drugs-showing-promise-as-treatments/
Semaglutide and tirzepatide, both once weekly injections, have shown significant reduction in body weight with tolerable side effects. These interventions are forecasting a shift in weight loss medication.